Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
51.08
+0.30 (0.59%)
At close: Feb 10, 2026, 4:00 PM EST
51.08
0.00 (0.00%)
After-hours: Feb 10, 2026, 7:00 PM EST
Qiagen Revenue
In the year 2025, Qiagen had annual revenue of $2.09B with 5.65% growth. Qiagen had revenue of $540.42M in the quarter ending December 31, 2025, with 3.69% growth.
Revenue (ttm)
$2.09B
Revenue Growth
+5.65%
P/S Ratio
5.08
Revenue / Employee
$350,260
Employees
5,967
Market Cap
10.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.09B | 111.79M | 5.65% |
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
| Dec 31, 2018 | 1.50B | 84.31M | 5.95% |
| Dec 31, 2017 | 1.42B | 79.55M | 5.95% |
| Dec 31, 2016 | 1.34B | 57.01M | 4.45% |
| Dec 31, 2015 | 1.28B | -63.79M | -4.74% |
| Dec 31, 2014 | 1.34B | 42.79M | 3.29% |
| Dec 31, 2013 | 1.30B | 47.53M | 3.79% |
| Dec 31, 2012 | 1.25B | 84.71M | 7.24% |
| Dec 31, 2011 | 1.17B | 82.32M | 7.57% |
| Dec 31, 2010 | 1.09B | 194.46M | 21.78% |
| Dec 31, 2008 | 892.98M | 243.20M | 37.43% |
| Dec 31, 2007 | 649.77M | 184.00M | 39.50% |
| Dec 31, 2006 | 465.78M | 67.38M | 16.91% |
| Dec 31, 2005 | 398.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Quest Diagnostics | 10.85B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Waters | 3.17B |
| Exact Sciences | 3.08B |
| Revvity | 2.86B |
| Medpace Holdings | 2.36B |
QGEN News
- 5 days ago - Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - Business Wire
- 7 days ago - QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - Business Wire
- 14 days ago - Qiagen: Takeover Optionality With A High-Quality Consumables Platform - Seeking Alpha
- 15 days ago - QIAGEN Appoints Mark Stevenson to Supervisory Board - Business Wire
- 20 days ago - Qiagen Explores Possible Sale After New Buyer Talks: Report - Benzinga
- 21 days ago - Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports - Reuters
- 22 days ago - QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast - Business Wire